LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women

NCT05303636 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

1536

Enrollment

INDUSTRY

Sponsor class

Conditions

Change in Bone Mineral Density
Bone Loss

Interventions

DRUG: drospirenone 4 mg oral tablet or drospirenone 3.5 mg chewable tablet

Sponsor

Insud Pharma

Collaborators

[object Object]